Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Infectious Disease

RSS  

Articles

  • Panton-Valentine Leukocidin

    Community-Associated MRSA (CA-MRSA) has emerged as an important cause of skin and soft-tissue infection. Most isolates of CA-MRSA are positive for the Panton-Valentine leukocidin (PVL), an exotoxin that is generally absent from "classic" hospital-associated MRSA strains. This suggests that PVL may be an important virulence determinant in CA-MRSA.
  • Human Papillomavirus Vaccine: For Boys, Too?

    The new quadrivalent Human Papillomavirus (HPV) L1 virus-like particle vaccine (types 6, 11, 16, 18) was studied for immunogenicity and reactogenicity in 506 girls and 510 boys (10-15 years of age) and 513 young women (16-23 years of age). Vaccine was administered in the standard schedule of 0, 2, and 6 months. Type-specific serologies were performed in a blinded fashion using a competitive Luminex xMAP-based immunoassay (cLIA) on serum samples obtained at 0, 3, and 7 months.
  • Listeria Meningitis

    Of 696 episodes of community-acquired meningitis in adults identified by the nationwide Dutch Meningitis Cohort study from 1998 to 2002, 30 (4%) were due to Listeria monocytogenes. The mean age was 65 ± 18 years; all 10 of the previously immunocompetent patients were >50 years of age.
  • Updates By Carol A. Kemper, MD, FACP

    Within the United States, 3 groups of individuals have been deemed the highest priority for annual influenza vaccination based on estimates of risk: (1) Persons ¡Ý 65 yrs; (2) Persons 18-64 yrs with chronic health conditions such as cardiorespiratory disease or who reside in a long-term care facility; (3) and health care workers and other persons with close contact with groups 1 and 2.
  • New Once-a-Day Pill Submitted to FDA

    HIV antiretroviral therapy treatment soon will become a whole lot simpler than most antibiotic regimens when the FDA approves the combination pill of efavirenz/emtricitabine/ tenofovir (Truvada/Sustiva).
  • Treatment of Cholera in Adults with Single-Dose Azithromycin

    This article originally appeared in the August 2006 issue of Travel Medicine Advisor. It was edited by Frank Bia, MD, MPH, and peer reviewed by Philip R. Fischer, MD, DTM&H. Dr. Fishcer is Professor of Pediatrics, Divsion of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN. Dr. Fishcer reports no financial relationships relevant to this field of study.
  • Multidrug-Resistant Tuberculosis (MDR-TB)

    The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance began collecting its data in 1994 on drug resistance in 90 countries.
  • Update on Guillain-Barré Syndrome and Menactra® Meningococcal Conjugate Vaccine

    In October of 2005, the first reports of 5 cases and the possible association of Guillain-Barré Syndrome (GBS) and recipients of Menactra® Meningococcal Conjugate Vaccine (MCV4) were reported.
  • Pharmacology Watch: Study: Long-Term Use of Clopidogrel for DES Patients

    Drug Labels A Prescription for Misunderstanding?; Osteonecrosis of the Jaw New Side-Effect to Bisphosphate Use; Beta-Blockers and Depression Unlinked?; FDA Actions
  • Fever, Rash, and Severe Arthralgias in Travelers Returning from India

    A 56-year-old man, originally from india and with a history of hypertension, had developed bilateral red, swollen ankles while on a recent trip to Bangalore. Five days later, the patient developed severe fever and shaking chills that resolved within 48 hrs.